Be part of the knowledge.™

The Newest Cardiac Marker Test: PLAC Test

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Dr. Larry Kaskel is joined by Dr. Rick Lanman, the Chief Medical Officer of biotech company Diadexus Inc. They will discuss the viability, accuracy, uniqueness and benefits of the PLAC Test.

Richard Lanman, MD

Richard Lanman, MD

Larry Kaskel, MD

Larry Kaskel, MD

Recommended

Details

Presenters

Overview
Dr. Larry Kaskel is joined by Dr. Rick Lanman, the Chief Medical Officer of biotech company Diadexus Inc. They will discuss the viability, accuracy, uniqueness and benefits of the PLAC Test.

Richard Lanman, MD

Richard Lanman, MD

Larry Kaskel, MD

Larry Kaskel, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway

Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective

I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis

M3: Managing the Cardiometabolic Risk in MASH

Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli

Impact of Barostim on Heart Failure Hospitalization

Navigating Myasthenia Gravis in Adolescents and Young Adults

Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids